Journal of the Japan Society for Healthcare Administration
Online ISSN : 2185-422X
Print ISSN : 1882-594X
ISSN-L : 1882-594X
Research notes
Productivity losses in pharmacoeconomic guidelines in Europe and Asia
Mitsuhiro NaganoAkira YuasaNaohiro YonemotoShunya Ikeda
Author information
JOURNAL FREE ACCESS

2023 Volume 60 Issue 2 Pages 62-72

Details
Abstract

Backgrounds: The costs considered in health technology assessment, including cost-effectiveness analysis (CEA) may vary depending on the healthcare systems in countries and regions (hereinafter collectively referred to as “countries”). This study aimed to investigate the differences in analysis perspectives and considerations of productivity losses in each country.

Methods: We conducted a qualitative review of the guidelines relevant to CEA in European and Asian countries to investigate the recommended perspectives of guidelines and the descriptions of productivity losses.

Results: A total of 33 countries were surveyed. Fourteen countries (42.4%) recommended at least one of the societal and other perspectives. In these countries, all (100.0%) mentioned patients’ productivity losses, of which 9 (64.3%) also addressed caregivers’ productivity losses.

Conclusions: About 40% of the surveyed countries allowed the inclusion of productivity losses in the base analysis. Since the subjects to be considered for productivity loss and the calculation methods differ among countries, it is necessary to be careful in the intercomparison of the analysis results.

Content from these authors
© 2023 Japan Society for Healthcare Administration
Previous article Next article
feedback
Top